CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Farmácia from Universidade Federal de Juiz de Fora (2016), master's at Pharmacy from Universidade de São Paulo (2018) and doctorate at Pharmacy from Universidade de São Paulo (2022). Has experience in Pharmacy, focusing on Pharmaceutical technology (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Breast cancer has a high worldwide prevalence and is the leading cause of cancer-related death among women. The treatment approach depends on the tumor's molecular subtype (luminal A, luminal B, HER2, and triple-negative) and may include surgical procedures, radiotherapy, and systemic therapy. Despite advances in systemic treatments over recent decades, the development of adverse effects …
Breast cancer is a complex disease, characterized by irregular cell growth, accounting for 30% of cancers in women, with a mortality rate of 15%. Most cases are related to family history or genetic predisposition and the associated germline mutations are found in the BRCA1 and BRCA2 genes. Despite all efforts, the treatments used for breast cancer are still very invasive and end up weaken…
Breast cancer accounts for approximately 11-12% of all diagnosed cancer worldwide, representing the main cause of death among women. Among them, about 20% of patients have overexpression of human epithelial receptor (HER2), which is associated with higher lethality and susceptibility to brain metastasis. Epirubicin (EPI) is a potent chemotherapeutic agent used in breast cancer treatment, …
Ovarian cancer is the most lethal gynecologic malignancy. It is estimated that in the year 2020 about 7,162 women will be diagnosed with ovarian cancer and the average mortality in the same year is estimated in 4,905 deaths. The high lethality is related with the lack of specific symptoms and a reliable early detection tests. Thus, approximately 70% of all patients are diagnosed with adva…
| 1 / 1 | Ongoing scholarships in Brazil |
| 3 / 3 | Completed scholarships in Brazil |
| 4 / 4 | All Scholarships |
| Associated processes | |